Pembrolizumab (Keytruda) Injection from Germany
Pembrolizumab targets PD-1 for advanced cancer immunotherapy like Hodgkin lymphoma. HTS 3002.15.00.11 covers this monoclonal antibody immunological product in pre-filled syringes for retail therapeutic use.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include BLA number and monoclonal sequence data in entry summary
• Monitor for counterfeit risks; use serialized packaging verification